Mark J. Rosenblum - Nov 3, 2022 Form 4/A - Amendment Insider Report for Salarius Pharmaceuticals, Inc. (SLRX)

Role
Exec VP Finance, CFO
Signature
/s/ Mark J. Rosenblum
Stock symbol
SLRX
Transactions as of
Nov 3, 2022
Transactions value $
$12,682
Form type
4/A - Amendment
Date filed
11/8/2022, 04:40 PM
Date Of Original Report
Nov 7, 2022
Previous filing
May 31, 2022
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLRX Common Stock Award $12.7K +7.31K +123.32% $1.73 13.2K Nov 3, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Salarius Pharmaceuticals, Inc. 2015 Employee Stock Purchase Plan, as amended, in transactions that were exempt under both Rule 16b-3(d) and Rule Rule 16b-3(c)